New York City enacted Local Law 2026/050 on January 29, 2026, when the City Council overrode a mayoral veto of Bill 1297-A. The amendment to the Gender-Motivated Violence Act (GMVA) creates an 18-month civil revival window running through July 29, 2027, and, critically, expressly permits claims against “enabling institutions” on conduct that occurred before the original 2022 statute.
The amendment also revives cases dismissed between March 2023 and March 2025 under the prior framework, allowing plaintiffs to refile or amend during the window.
Who it affects
Any self-insured institution with an NYC nexus: hospital systems, universities, school districts, municipal employers, religious bodies, large private employers, and public authorities. The exposure flows through general liability, educators’ and public officials’ liability, and sexual-abuse/molestation (SAM) coverages, often sitting inside a captive or a high self-insured retention. Out-of-state defendants with NYC operations face a venue fight but should not assume they are insulated.
The reserve mechanism
The dominant impact is a case reserve adequacy problem on historical inventories. Claims tied to pre-2022 conduct were, in many instances, coded as closed or carried at nominal reserves because the statute of limitations had run. Those files now need to be reopened and reserved against live litigation exposure. For programs that follow the public entity GL reserving playbook, this is the latent-claim revival dynamic familiar from the New York Child Victims Act window of 2019 to 2021, applied to a broader class of defendants and a shorter filing runway.
The second impact is a frequency lift in pure IBNR for long-tail abuse and misconduct lines. Unreported survivors who were previously barred now have standing, and the plaintiff bar is already marketing the window. Actuaries benchmarking the loading should triangulate against CVA filing rates (roughly 11,000 suits filed in the two-year window) scaled for the broader institutional scope and shorter duration of the GMVA window.
The third is a development pattern that lengthens the reported-to-paid tail. Revival-window claims tend to aggregate into multi-plaintiff bundles, settle late, and carry defense costs that ramp as institutional discovery proceeds. For hospital systems, these dynamics compound the existing captive gross-to-net wrinkle when prior-acts wording on tail treaties is tested.
What to ask your actuary
- What IBNR loading have you applied to pre-2022 NYC exposure, and how was it benchmarked against CVA filing rates and the defendant population actually reachable under the “enabling institution” language?
- Should revival-window reserves be segregated from ongoing GL IBNR so the triangle is not permanently distorted by a one-off filing surge?
- Do our tail policies, prior-acts endorsements, or captive reinsurance treaties respond to claims filed in 2026 or 2027 for acts occurring in the 1980s or 1990s, and have we documented coverage counsel’s read?
What to watch next
The first wave of motions to dismiss will test two questions that drive the ultimate exposure: whether NYC has authority to revive state-law claims, and how broadly courts will construe “enabling institution.” A ruling either way in the first six months of filings will move reserve indications materially in either direction.